Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP658106.RAtn6-Dd4LuaiGSshXxgRLwF6b8ePcGo4BgLwyrdlc38E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP658106.RAtn6-Dd4LuaiGSshXxgRLwF6b8ePcGo4BgLwyrdlc38E130_assertion type Assertion NP658106.RAtn6-Dd4LuaiGSshXxgRLwF6b8ePcGo4BgLwyrdlc38E130_head.
- NP658106.RAtn6-Dd4LuaiGSshXxgRLwF6b8ePcGo4BgLwyrdlc38E130_assertion wasGeneratedBy ECO_0000203 NP658106.RAtn6-Dd4LuaiGSshXxgRLwF6b8ePcGo4BgLwyrdlc38E130_provenance.
- NP658106.RAtn6-Dd4LuaiGSshXxgRLwF6b8ePcGo4BgLwyrdlc38E130_assertion wasDerivedFrom befree-20150227 NP658106.RAtn6-Dd4LuaiGSshXxgRLwF6b8ePcGo4BgLwyrdlc38E130_provenance.
- NP658106.RAtn6-Dd4LuaiGSshXxgRLwF6b8ePcGo4BgLwyrdlc38E130_assertion SIO_000772 17616668 NP658106.RAtn6-Dd4LuaiGSshXxgRLwF6b8ePcGo4BgLwyrdlc38E130_provenance.
- NP658106.RAtn6-Dd4LuaiGSshXxgRLwF6b8ePcGo4BgLwyrdlc38E130_assertion evidence source_evidence_literature NP658106.RAtn6-Dd4LuaiGSshXxgRLwF6b8ePcGo4BgLwyrdlc38E130_provenance.
- NP658106.RAtn6-Dd4LuaiGSshXxgRLwF6b8ePcGo4BgLwyrdlc38E130_assertion description "[Finally, treatment of glioma cell lines with prostaglandin E2, the predominant product of COX-2 activity, results in increased vascular endothelial growth factor expression, thus potentially linking elevations in COX-2 expression with tumor angiogenesis in malignant gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658106.RAtn6-Dd4LuaiGSshXxgRLwF6b8ePcGo4BgLwyrdlc38E130_provenance.